Advertisement
Screener

United Therapeutics Corporation (UTHR) Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets

2.8 / 5 stars · 68/120 Roast Me

United Therapeutics Corporation Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets

United Therapeutics Corporation (UTHR) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets of $149.00 million as of 2018-08-30, per its 10-K filed 2019-02-27.

Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less) › Business Combination, Recognized Asset Acquired, Asset

us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets · last filed 2019-02-27

  • 2018-08-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets $149.00M; Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets as first filed $145.80M.
Period endBusiness Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, AssetsBusiness Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets as first filed
2018-08-30$149.00M
10-K · filed 2019-02-27
$145.80M
10-Q · filed 2018-10-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Viatris Inc (VTRS)United States$20.008B-0.00
Royalty Pharma plc (RPRX)United States$22.628B
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
INSMED Inc (INSM)United States$26.566B-26.60
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17